This is the authors' abstract. We don't add key points for this paper.
Dysregulation of regulatory T cells (Tregs) is a hallmark of immune imbalance in ulcerative colitis (UC), in which their suppressive function relies heavily on post-translational modifications and the stabilization of the transcription factor Foxp3. However, the upstream regulatory mechanisms remain poorly understood. Here, we identify ADP-ribosylation factor 1 (Arf1) as a key regulator of Treg function. Clinical samples from UC patients revealed an inverse correlation between ARF1 expression in Tregs and disease severity. Using a Treg-specific Arf1 knockout mouse model, we demonstrate that Arf1 deficiency impairs induced Treg (iTreg) differentiation, disrupts suppressive function, and aggravates T cell transfer-induced colitis. Mechanistically, Arf1 sustains mitochondrial integrity and represses histone deacetylase 9 (Hdac9), thereby enhancing FOXP3 acetylation and protein stability. These findings establish Arf1 as a critical upstream modulator of Treg cell function and intestinal immune homeostasis, and highlight the ARF1-HDAC9-FOXP3 axis as a promising target for Treg-based therapeutic strategies in UC.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: